168 related articles for article (PubMed ID: 29681367)
1. Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients With Atrial Fibrillation.
Hernandez I; Zhang Y; Saba S
Am J Cardiol; 2018 Jul; 122(1):69-75. PubMed ID: 29681367
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population.
Gupta K; Trocio J; Keshishian A; Zhang Q; Dina O; Mardekian J; Nadkarni A; Shank TC
BMC Cardiovasc Disord; 2019 Jun; 19(1):142. PubMed ID: 31195999
[TBL] [Abstract][Full Text] [Related]
3. Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation.
Skjøth F; Larsen TB; Dun AR; Lilja M; Rahman I; Abdelgawwad K; Halvorsen S; Coleman C; Rivera M
Am J Med; 2024 Jun; 137(6):520-528.e13. PubMed ID: 38387539
[TBL] [Abstract][Full Text] [Related]
4. Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study.
Lehto M; Luojus A; Halminen O; Haukka J; Putaala J; Linna M; Mustonen P; Kinnunen J; Lehtonen O; Teppo K; Tiili P; Kouki E; Itäinen-Strömberg S; Niemi M; Aro AL; Hartikainen J; Airaksinen KEJ;
Ann Med; 2024 Dec; 56(1):2364825. PubMed ID: 38873855
[TBL] [Abstract][Full Text] [Related]
5. Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland.
Mueller T; Alvarez-Madrazo S; Robertson C; Wu O; Bennie M
Br J Clin Pharmacol; 2019 Feb; 85(2):422-431. PubMed ID: 30423191
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure.
Martinez BK; Bunz TJ; Eriksson D; Meinecke AK; Sood NA; Coleman CI
ESC Heart Fail; 2019 Feb; 6(1):10-15. PubMed ID: 30299591
[TBL] [Abstract][Full Text] [Related]
7. Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method.
Ngufor C; Yao X; Inselman JW; Ross JS; Dhruva SS; Graham DJ; Lee JY; Siontis KC; Desai NR; Polley E; Shah ND; Noseworthy PA
Am Heart J; 2023 Jun; 260():124-140. PubMed ID: 36893934
[TBL] [Abstract][Full Text] [Related]
8. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation.
Yao X; Abraham NS; Alexander GC; Crown W; Montori VM; Sangaralingham LR; Gersh BJ; Shah ND; Noseworthy PA
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26908412
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation.
Binding C; Blanche P; Lip GYH; Kamper AL; Lee CJY; Staerk L; Gislason G; Torp-Pedersen C; Olesen JB; Bonde AN
Eur Heart J Cardiovasc Pharmacother; 2024 May; 10(3):210-218. PubMed ID: 38402466
[TBL] [Abstract][Full Text] [Related]
10. Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack.
Patel PA; Zhao X; Fonarow GC; Lytle BL; Smith EE; Xian Y; Bhatt DL; Peterson ED; Schwamm LH; Hernandez AF
Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):383-92. PubMed ID: 26058721
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice: A Cohort Study.
Fralick M; Colacci M; Schneeweiss S; Huybrechts KF; Lin KJ; Gagne JJ
Ann Intern Med; 2020 Apr; 172(7):463-473. PubMed ID: 32150751
[TBL] [Abstract][Full Text] [Related]
12. Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study.
Li X; Zuo C; Ji Q; Xue Y; Wang Z; Lv Q
Drug Des Devel Ther; 2021; 15():1931-1943. PubMed ID: 33986592
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different direct oral anticoagulant regimens in atrial fibrillation patients with high bleeding risk.
Ciou WS; Wang CC; Lin FJ; Chao TF; Lin SY
Heart Rhythm; 2024 Jun; 21(6):715-722. PubMed ID: 38266751
[TBL] [Abstract][Full Text] [Related]
14. How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation.
Schaefer JK; McBane RD; Wysokinski WE
Ann Hematol; 2016 Feb; 95(3):437-49. PubMed ID: 26658769
[TBL] [Abstract][Full Text] [Related]
15. Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care.
Allan V; Banerjee A; Shah AD; Patel R; Denaxas S; Casas JP; Hemingway H
Heart; 2017 Feb; 103(3):210-218. PubMed ID: 27580623
[TBL] [Abstract][Full Text] [Related]
16. Sex-Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation.
Palamaner Subash Shantha G; Mentias A; Inampudi C; Kumar AA; Chaikriangkrai K; Bhise V; Deshmukh A; Patel N; Pancholy S; Horwitz PA; Mickelsen S; Bhave PD; Giudici M; Oral H; Vaughan Sarrazin MS
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862952
[TBL] [Abstract][Full Text] [Related]
17. Net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation based on a CHA
Methavigul K; Chichareon P; Yindeengam A; Krittayaphong R
BMC Cardiovasc Disord; 2023 Dec; 23(1):623. PubMed ID: 38114960
[TBL] [Abstract][Full Text] [Related]
18. A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulants.
Ajao A; Cosgrove A; Eworuke E; Mohamoud M; Zhang R; Shapira O; Kolonoski J; Connolly JG
Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1164-1173. PubMed ID: 35909259
[TBL] [Abstract][Full Text] [Related]
19. Apixaban to prevent stroke in patients with atrial fibrillation: a review.
Peterson BE; Al-Khatib SM; Granger CB
Ther Adv Cardiovasc Dis; 2017 Mar; 11(3):91-104. PubMed ID: 27342651
[TBL] [Abstract][Full Text] [Related]
20. Vitamin-K-antagonist phenprocoumon versus direct oral anticoagulants in patients with atrial fibrillation: a real-world analysis of German claims data.
Warkentin L; Klohn F; Deiters B; Kühlein T; Hueber S
BMJ Open; 2023 Jan; 13(1):e063490. PubMed ID: 36593002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
